- The FreeStyle Libre 3 system automatically delivers real-time, up-to-the-minute glucose readings, unsurpassed 14-day accuracy[1] and optional glucose alarms directly to smartphones[2] for people ...
- Findings from the RELIEF study in France showed for the first time, in the largest retrospective analysis of its kind of nearly 75,000 people living with diabetes, use of the FreeStyle Libre system ...
ABBOTT PARK, Ill., June 13, 2020 /CNW/ -- Today, Abbott (NYSE: ABT) announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world's leading 3 continuous glucose ...
ABBOTT PARK, Ill., Sept. 28, 2020 /PRNewswire/ -- Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM) technology, 8 announced today it has secured CE Mark (Conformité ...
Collaboration brings together FreeStyle Libre ® Systems, the world's leading continuous glucose monitoring technology (CGM) 1 with Epic, a healthcare software company, to streamline access to CGM data ...
The FreeStyle Libre glucose monitoring system (Abbott Diabetes Care) is accurate and safe in a pediatric population, new data show. The FreeStyle Libre System comprises a small round glucose sensor ...
Global medical device company Abbott Laboratories (NYSE:ABT) has been constantly making efforts to expand its diabetes care business. The company recently announced the receipt of Health Canada ...
Expanded use of FreeStyle Libre system allows health care workers in hospital and professional health care settings to remotely monitor expectant mothers' glucose status to minimize exposure to ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile